Why is QMS Medical falling/rising?

As of 03-Jul, QMS Medical Allied Services Ltd is experiencing a decline in its stock price, currently at 79.15, reflecting a decrease of 4.35 or 5.21%. The stock has underperformed its sector by 3.97% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 8.76%, and year-to-date, it has fallen by 30.23%. Additionally, there has been a significant drop in investor participation, with delivery volume decreasing by 43.18% compared to the 5-day average. Despite these challenges, the company reported positive results for March 25, including the highest quarterly PBDIT and net sales, along with a favorable PEG ratio of 0.9, indicating a potentially attractive valuation compared to peers.
In the broader market context, the Sensex has shown a modest decline of 0.56% over the past week, contrasting sharply with QMS Medical's significant drop. While the stock has underperformed the benchmark considerably, it is noteworthy that its profits have risen by 16% over the past year, despite the stock's steep decline of 44.63% during the same period. This suggests that while the company's fundamentals may be improving, external market conditions and investor sentiment are currently weighing heavily on the stock's performance.